InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Discover the complete record of transactions filed by Klein Matthew B., Directeur et COO. Director active across 2 companies, notably ClearPoint Neuro, Inc.. Cumulatively, 8 filings have been recorded. Total volume traded: €88k. The latest transaction was filed on 13 May 2026 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations8 total
012,500 shares0
Common Stock
SEC:0001808968-26-000015·
012,500 shares0
Common Stock
SEC:0001808968-26-000015:0·
09,269 shares0
Common Stock
SEC:0001420506-22-001135:0·
€35,329897 shares@ €39.38590.0006% mcap40.1% of flow
Common Stock
SEC:0001415889-22-004211:0·
€26,429775 shares@ €34.10230.0004% mcap100.0% of flow
Common Stock
SEC:0001179110-22-000397·
€26,429775 shares@ €34.10230.0004% mcap30.0% of flow
Common Stock
SEC:0001179110-22-000397:0·
03,003 shares0
Common Stock
SEC:0001171520-21-000266·
03,003 shares0
Common Stock
SEC:0001171520-21-000266:0·
8 of 8 declarations
About Klein Matthew B.
Matthew B. Klein is a Director and COO at ClearPoint Neuro, Inc. and PTC THERAPEUTICS, INC. He oversees operations and contributes to the growth strategy of these companies.
